FDA Orange Book · active-ingredient family
Dimethyl fumarate
Dimethyl fumarate: 1 brand, 17 generics; first approved Mar 27, 2013; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 17 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
1
Generics (ANDA)
17
Listed patents
9
Next patent expiry
Feb 07, 2028
in 1 yr 6 mo
Brand (NDA) products
Originator applications
- TECFIDERARLDBIOGENNDA 20406320132 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB
Generic (ANDA) products (17)
Abbreviated applications
- DIMETHYL FUMARATETORRENTANDA 21039020252 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Discontinued — 240MG CAPSULE, DELAYED RELEASE ORAL Discontinued — - DIMETHYL FUMARATEMACLEODS PHARMS LTDANDA 21037720242 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEAUROBINDO PHARMAANDA 21038520222 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEPRINSTON INCANDA 21041420222 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATESAWAI USAANDA 21028520212 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Discontinued — 240MG CAPSULE, DELAYED RELEASE ORAL Discontinued — - DIMETHYL FUMARATESOLA PHARMSANDA 21043620212 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATETWI PHARMSANDA 21038220202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEGLENMARK PHARMS LTDANDA 21030920202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATELUPINANDA 21022620202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEACCORD HLTHCAREANDA 21049920202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEALKEM LABS LTDANDA 21044020202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEAMNEALANDA 21040220202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATECIPLAANDA 21030520202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Discontinued — 240MG CAPSULE, DELAYED RELEASE ORAL Discontinued — - DIMETHYL FUMARATEHETERO LABS LTD IIIANDA 21050020202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEMSNANDA 21046020202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Rx AB 240MG CAPSULE, DELAYED RELEASE ORAL Rx AB - DIMETHYL FUMARATEZYDUS PHARMSANDA 21053820202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Discontinued — 240MG CAPSULE, DELAYED RELEASE ORAL Discontinued — - DIMETHYL FUMARATEMYLANANDA 21053120202 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 120MG CAPSULE, DELAYED RELEASE ORAL Discontinued — 240MG CAPSULE, DELAYED RELEASE ORAL Discontinued —
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 8399514 | in 1 yr 6 mo | U-1384 | |
| 10391160 | in 8 yr 9 mo | U-3148 | |
| 10555993 | in 8 yr 9 mo | U-3148 | |
| 10994003 | in 8 yr 9 mo | U-3148 | |
| 10959972 | in 9 yr 5 mo | U-1384 | |
| 11129806 | in 9 yr 5 mo | U-1384 | |
| 11007166 | in 9 yr 5 mo | U-1384 | |
| 11007167 | in 9 yr 5 mo | U-1384 | |
| 11246850 | in 9 yr 5 mo | U-1384 |
Approval history
FDA approval span
First approval
13 yr 7 mo ago
Most recent approval
1 yr 7 mo ago
Approvals span 2013–2025 across 18 FDA applications.
Brand (NDA) 16%
Generic (ANDA) 1794%
Dimethyl fumarate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

